COST EFFECTIVENESS OF PEMETREXED/CISPLATIN (PEM/CIS) IN THE TREATMENT OF ADVANCED, NON-SQUAMOUS, NON-SMALL CELL LUNG CANCER (NSQNSCLC) PATIENTS

被引:0
|
作者
Winfree, K. B. [1 ]
Shah, M. [2 ]
Peterson, P. [3 ]
Gruschkus, S. [2 ]
Eaddy, M. [2 ]
Green, M. [2 ]
机构
[1] Eli Lilly & Co, Global Hlth Outcomes Oncol, Indianapolis, IN 46285 USA
[2] Xcenda AmerisourceBergen Consulting Serv, Oncol, Palm Harbor, FL USA
[3] Eli Lilly & Co, Oncol Stat, Indianapolis, IN 46285 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:428 / 428
页数:1
相关论文
共 50 条
  • [1] Pemetrexed and Cisplatin for Advanced Non-squamous Non-small Cell Lung Cancer in Japanese Patients: Phase II Study
    Kawano, Yuko
    Ohyanagi, Fumiyoshi
    Yanagitani, Noriko
    Kudo, Keita
    Horiike, Atsushi
    Tanimoto, Azusa
    Nishizawa, Hironari
    Ichikawa, Atsuo
    Sakatani, Toshio
    Nakatomi, Katsumi
    Hagiwara, Sachiko
    Ninomiya, Hironori
    Motoi, Noriko
    Ishikawa, Yuichi
    Horai, Takeshi
    Nishio, Makoto
    [J]. ANTICANCER RESEARCH, 2013, 33 (08) : 3327 - 3333
  • [2] Feasibility of cisplatin/pemetrexed with 15 mg/kg bevacizumab for the treatment of patients with advanced non-squamous non-small cell lung cancer
    Hirai, Fumihiko
    Seto, Takashi
    Inamasu, Eiko
    Shimokawa, Mototsugu
    Toyokawa, Gouji
    Yoshida, Tsukihisa
    Nosaki, Kaname
    Takenaka, Tomoyoshi
    Yamaguchi, Masafumi
    Takenoyama, Mitsuhiro
    Ichinose, Yukito
    [J]. ONCOLOGY LETTERS, 2015, 9 (06) : 2577 - 2582
  • [3] Cost-Effectiveness of Pemetrexed for Advanced Non-Squamous Non-Small Cell Lung Cancer (nsNSCLC) in Patients Treated in a Spanish Institution
    Mielgo Rubio, Xabier
    Martinez Cabanes, Ruth
    Velastegui, Alejandro
    Rosero, Adriana
    Ruiz-Gimenez, Leticia
    Aguayo, Cristina
    Garcia Ferron, Maria
    Silva, Jorge
    Perez Fernandez, Elia
    Jara, Carlos
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S419 - S419
  • [4] Pemetrexed versus vinorelbine treatment of advanced non-squamous non-small cell lung cancer in elderly patients
    Chen, Yongshun
    Wen, Qinglian
    Liu, Hao
    Ao, Rui
    Wu, Xiaoyuan
    Guo, Leiming
    Wang, Wen
    He, Chunyu
    Wang, Jianhua
    [J]. MOLECULAR AND CLINICAL ONCOLOGY, 2013, 1 (03) : 553 - 557
  • [5] INDIRECT COMPARISON OF EFFICACY, SAFETY, AND COST: PEMETREXED/CISPLATIN VERSUS BEVACIZUMAB/GEMCITABINE/CISPLATIN IN PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER
    Orlando, Mauro
    Barraclough, Helen
    Orlov, Sergey
    Rajan, Narayan
    Davey, Peter
    Kanivets, Yana
    Han, Baoguang
    Brnabic, Alan
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1232 - S1233
  • [6] PHARMACOGENETIC STUDY OF JAPANESE PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER TREATED WITH PEMETREXED PLUS CISPLATIN
    Imai, Hisao
    Takahashi, Toshiaki
    Serizawa, Masakuni
    Mori, Keita
    Ono, Akira
    Akamatsu, Hiroaki
    Taira, Tetsuhiko
    Nakamura, Yukiko
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Murakami, Haruyasu
    Koh, Yasuhiro
    Endo, Masahiro
    Nakajima, Takashi
    Yamamoto, Nobuyuki
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1077 - S1077
  • [7] Feasibility of home delivery of pemetrexed in patients with advanced non-squamous non-small cell lung cancer
    Lal, R.
    Hillerdal, G. N.
    Shah, R. N. H.
    Crosse, B.
    Thompson, J.
    Nicolson, M.
    Vikstrom, A.
    Potter, V. A.
    Visseren-Grul, C.
    Lorenzo, M.
    D'yachkova, Y.
    Bourayou, N.
    Summers, Y. J.
    [J]. LUNG CANCER, 2015, 89 (02) : 154 - 160
  • [8] EFFICIENCY OF CISPLATIN, PEMETREXED, AND BEVACIZUMAB AS FIRST-LINE TREATMENT FOR JAPANESE ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER PATIENTS
    Shiraishi, Yoshimasa
    Hirai, Humihiko
    Yamaguchi, Masafumi
    Morodomi, Yosuke
    Toyozawa, Ryo
    Inamasu, Eiko
    Kojo, Miyako
    Toyokawa, Gouji
    Takenaka, Tomoyoshi
    Seto, Takashi
    Takenoyama, Mitsuhiro
    Ichinose, Yukito
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S488 - S488
  • [9] Pemetrexed/cisplatin (pem/cis) Vs. Pemetrexed/carboplatin (pem/carbo) In Non-squamous, Non-small Cell Lung Cancer (nsclc): A Retrospective Comparison Using A Large Electronic Database
    Hoverman, J. R.
    Sheth, S.
    Clayton, M.
    Neubauer, M.
    Brooks, B.
    Garey, J.
    Beveridge, R.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : S273 - S273
  • [10] Luminespib plus pemetrexed in patients with non-squamous non-small cell lung cancer
    Noor, Zorawar S.
    Goldman, Jonathan W.
    Lawler, William E.
    Telivala, Bijoy
    Braiteh, Fadi
    DiCarlo, Brian A.
    Kennedy, Kathleen
    Adams, Brad
    Wang, Xiaoyan
    Jones, Benjamin
    Slamon, Dennis J.
    Garon, Edward B.
    [J]. LUNG CANCER, 2019, 135 : 104 - 109